OOIR: Observatory of International Research

Papers

(The TQCC of International Journal of Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
DORSAL CA3 NEURAL ACTIVITY MEDIATES WITNESSING STRESS- INDUCED RECOGNITION MEMORY DEFICITS IN ADOLESCENT MALE MICE	225
CONTRIBUTION OF 5-HT2AR TO THE ANTI-ANHEDONIC AND NEUROPLASTICITY EFFECTS OF PSYCHEDELICS	97
GUSHANSKAYA EKATERINA VLADIMIROVNA, PSYCHIATRIST, PSYCHOTHERAPIST, CANDIDATE OF MEDICAL SCIENCES, HEAD OF THE DEPARTMENT OF PSYCHIATRY AT THE PSYCHIATRIC HOSPITAL 13, ASSOCIATE PROFESSOR OF THE DEPART	58
DEPRESSION AND ANTIDEPRESSANT USE IN PREGNANCY AND ADVERSE MATERNAL AND FETAL/CHILDREN OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS	46
POSSIBLE IMMUNOLOGICAL PATHOPHYSIOLOGY IN BIPOLAR DISORDER: REVERSE-TRANSLATIONAL RESEARCH USING INDUCED MICROGLIA-LIKE (IMG) CELLS	46
EVENAMIDE AS ADD-ON TREATMENT FOR TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) PATIENTS NOT BENEFITING FROM ANTIPSYCHOTICS: DESIGN OF A PHASE 3, POTENTIALLY PIVOTAL, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND	44
FACTORS ASSOCIATED WITH THE INITIATION OF LAXATIVE USE IN THE SAME PATIENTS WITH SCHIZOPHRENIA OVER A 20-YEAR PERIOD: RETROSPECTIVE COHORT STUDY	38
EFFECTS OF MULTIPLE NEUROPSYCHIATRIC MEDICATIONS DURING PREGNANCY ON NEONATAL ABSTINENCE SYNDROME (SECOND REPORT)	36
NPAS4 ENHANCER RNA FORMS DNA:RNA HYBRID R-LOOP TO CONTROL REWARD-RELATED BEHAVIORAL ADAPTATION THROUGH ACTIVITY-DEPENDENT GENE EXPRESSION	36
REGIONAL HOMOGENEITY CHANGES IN CEREBRAL AND CEREBELLAR REGIONS ASSOCIATED WITH DEFAULT-MODE NETWORK FOLLOWING PROLONGED INTERMITTENT THETA-BURST STIMULATION	35
PROTOTYPIC ANTIDEPRESSANTS ACT AS A G-PROTEIN BIASED LPAR1 AGONIST AND CONTRIBUTE TO ANTIDEPRESSANT EFFECTS	34
CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM	32
COURAGE AND TRANSFORMATION: PATIENT EXPERIENCES OF WEB- BASED EMDR FOR SUICIDAL IDEATION	32
INHIBITION OF HISTAMINE METABOLIZING ENZYME IN THE BRAIN REDUCES CATAPLEXY IN NARCOLEPSY MODEL MICE	28
NEURAL ACTIVITY CHANGES VIA DOPAMINE D1 RECEPTOR STIMULATION IN THE NUCLEUS ACCUMBENS MODULATE MOTIVATION FOR WHEEL RUNNING IN MICE	27
(2R,6R)-HYDROXYNORKETAMINE TARGETING THE BASOLATERAL AMYGDALA REGULATES FEAR MEMORY	27
589. PERIPUBERTAL STRESS EXERTS DIFFERENTIAL IMPACTS ON THALAMIC RETICULAR AND REUNIENS NUCLEI IN MALE VS FEMALE RATS	25
FUNCTIONAL ANALYSIS OF IPS CELL-DERIVED NEURONS FROM A PATIENT WITH 3Q29 DELETION	25
466. ASSESSING AND MANAGING CIGARETTE SMOKING AMONG PSYCHIATRIC INPATIENTS: CLINICAL AND SOCIODEMOGRAPHIC IMPLICATIONS	24
680. ASSESSING THE UTILITY OF ZURANOLONE TO MODIFY ALCOHOL-RELATED BEHAVIOURS	24
Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder	23
267. ETHNIC VARIABILITY IN RTMS DOSAGE: A CALL FOR ADAPTIVE THERAPEUTIC INNOVATION	21
328. DELAYED ONSET POST-STROKE MANIA, A CASE REPORT AND LITERATURE REVIEW	21
272. EFFECTIVENESS OF TRANSCRANIAL PULSE STIMULATION FOR MAJOR DEPRESSION: PRELIMINARY EVIDENCE FOR CLINICAL RESPONSE AND NEUROIMAGING MECHANISMS	21
329. DIFFERENTIALLY EXPRESSED PLATELET ONCOPROTEINS AND THEIR ASSOCIATION WITH PLASMA PROGRAMMED CELL DEATH LIGAND 1 IN BIPOLAR MANIC PATIENTS	21

467. THE NEUROANATOMY OF POSTPARTUM DEPRESSION: INSIGHTS FROM A CROSS-SECTIONAL STRUCTURAL MRI STUDY	21
370. ASSOCIATIONS OF POLYGENIC RISK SCORES DIFFERENTIATING ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM AUTISM SPECTRUM DISORDER WITH COGNITIVE AND CORTICAL ALTERATIONS IN SCHIZOPHRENIA PATIENTS	20
260. INSULIN-LIKE GROWTH FACTOR 1 IN THE BRAIN AND ADDICTION --- THE VULNERABLE PREFRONTAL CORTEX IN OPIOID USE DISORDER	19
495. USING SPATIALLY RESOLVED SINGLE-NUCLEUS MULTI-OMICS APPROACH TO UNDERSTAND HOW ADVERSITY CONTRIBUTES TO PSYCHIATRIC DISORDERS	19
Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study	18
Aromatase Inhibition and Electroconvulsive Seizures in Adolescent Rats: Antidepressant and Long-Term Cognitive Sex Differences	18
A Meta-Analysis of Neural Correlates of Reward Anticipation in Individuals at Clinical Risk for Schizophrenia	18
IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice	18
303. PATIENT AND CLINICIAN ACCEPTANCE OF RECENT TECHNOLOGICAL ADVANCES IN THE THERAPEUTIC MONITORING OF LITHIUM	17
A STUDY ON THE REGULATORY STATUS OF PSYCHEDELICS IN KOREA AND THEIR ADMISSIBILITY AS THERAPEUTIC AGENTS	17
Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms	17
Metabotropic Glutamate Receptor 5 as a Potential Biomarker of the Intersection of Trauma and Cannabis Use	16
TREATMENT DISENGAGEMENT AND APD TREATMENT IN EARLY PSYCHOSIS: RESULTS FROM EPINET – THE LARGEST EP NETWORK IN THE USA	16
ASSOCIATION BETWEEN ALLOSTATIC LOAD AND CARDIAC STRUCTURE IN ADULT PATIENTS WITH SCHIZOPHRENIA	16
PSYCHOSOMATIC SYMPTOMS IN TYPE 2 DIABETES PATIENTS: A NETWORK ANALYSIS	16
163. RELATIONSHIP BETWEEN CLOZAPINE: NORCLOZAPINE RATIO AND COGNITIVE FUNCTION AND EMPLOYMENT STATUS IN TREATMENT RESISTANT SCHIZOPHRENIA	15
CANNABINOID RECEPTOR TYPE 1-REGULATED CELL DEATH DEPENDING ON ITS SUBCELLULAR LOCALIZATION IN HUMAN NEUROBLASTOMA CELL	15
DEVELOPMENT OF A MULTIMODAL VR SYSTEM FOR CORTICAL FUNCTIONAL NETWORK ANALYSIS DURING MOUSE SOCIAL BEHAVIOR	15
233. DYNAMIC POSTURAL CONTROL IN REMITTED BIPOLAR I DISORDER: A CDP STUDY	14
421. THE RELATIONSHIP BETWEEN SLEEP QUALITY AND NEUROCOGNITIVE FUNCTION IN THE GERIATRIC DEPRESSION: A CASE-CONTROL STUDY	14
108. SELECTIVE POTENTIATION OF α5-GABAA RECEPTORS CONTRIBUTES TO REDUCTION OF COGNITIVE BURDEN AND NEURONAL LOSS IN AGING MICE	14
176. ANALYSIS OF THE EFFECT OF OXYTOCIN ANALOGUES ON A MOUSE CONTEXTUAL FEAR-CONDITIONING BEHAVIOR	14
160. CHANGES IN QUALITY OF LIFE AND PRODUCTIVITY GAIN AMONG ESKETAMINE RESPONDERS IN A REAL-WORLD STUDY IN AUSTRALIA AND NEW ZEALAND	14
DISTRIBUTION OF DOPAMINE PATHWAY GENE POLYMORPHISMS IN SUBJECTS WITH DIFFERENT SMOKING BEHAVIOR	14
522. TARGETING OPIOID NEUROTRANSMISSION IN BORDERLINE PERSONALITY DISORDER WITH SELF-HARMING BEHAVIOR: PRELIMINARY FINDINGS OF A [11C]NOP-1A POSITRON EMISSION TOMOGRAPHY STUDY	14
545. DEFICIENCY OF TBX1, A GENE ENCODED IN 22Q11.2 COPY NUMBER VARIATION, IMPAIRS SOCIAL AND COGNITIVE BEHAVIORS BY ALTERING BRAIN SHAPE AND NEONATAL STEM CELLS	14
388. COMMON AND DISTINCT EFFECTS OF 10-HZ RTMS AND ITBS ON STRIATUM-BASED FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER: A SHAM-CONTROLLED STUDY	14
Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies	13
Adjunctive brexpiprazole in patients with unresolved symptoms of depression on antidepressant treatment who are early in the disease course: post hoc analysis of randomized controlled trials	13
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3	13
SOCIAL INTERACTION SUPPRESSES COCAINE RELAPSE BY REGULATING DAERGIC ENGRAM INPUT OF VENTRAL TEGMENTAL AREA	13
JOBS STRESS LEADS TO PROFESSIONAL BURNOUT IN ADDICTION SPECIALISTS	12
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls	12
Corrigendum to: Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior	12
Default Mode Network Modulation by Psychedelics: A Systematic Review	12
DEVELOPMENTAL NICOTINE EXPOSURE AND COGNITIVE VULNERABILITY: IS THE IMMUNE SYSTEM INVOLVED?	11
EFFECTIVENESS AND SAFETY OF BLONANSERIN FOR IMPROVING SOCIAL AND COGNITIVE FUNCTIONS IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA	11
ANALYSIS OF DOPAMINE TRANSPORTER-EXPRESSING NEURON-SPECIFIC TYROSINE HYDROXYLASE KNOCKOUT MICE	11
EFFICACY OF LOW-DOSE INTERLEUKIN 2 AS ADD-ON IN THE TREATMENT OF UNIPOLAR AND BIPOLAR DEPRESSION	11
ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITAN	11
A RETROSPECTIVE COMPARATIVE STUDY OF CLINICAL RESPONSE TO CLOZAPINE BETWEEN PATIENTS WITH EARLY TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) AND LATE TRS	11
THE IOWA GAMBLING TASK NET SCORES IS ASSOCIATED WITH SOCIAL FUNCTION IN BIPOLAR DISORDER	11
CONNEXIN43 IN NEONATAL EXCITATORY NEURONS IS IMPORTANT FOR MOTOR LEARNING	11
MATERNAL EXPOSURE TO AIR POLLUTANT PM2.5 INDUCES AUTISTIC-LIKE BEHAVIOR IN OFFSPRING	11
Effect ofMAOADNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography	10
255. UNVEILING THE COGNITIVE ENHANCING EFFECTS OF RS-D7, A NOVEL NDMAR MODULATOR, ON HIPPOCAMPUS-DEPENDENT LEARNING AND MEMORY IN MICE	10
458. EFFECTIVENESS OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE ON RELAPSE PREVENTION OF SCHIZOPHRENIA	10
PREDICTION OF CLINICAL RESPONSE TO DONEPEZIL AND MEMANTINE IN PATIENTS WITH ALZHEIMER'S DISEASES BY USING EEG CONNECTIVITY	10
EXPLORING THE NEUROBIOLOGICAL AND PSYCHOLOGICAL MECHANISMS OF KETAMINE IN PROBLEMATIC GAMBLING: A MECHANISTIC STUDY	10
543. MODULATION OF BRAIN FUNCTIONS BY GLIAL RESET	10

548. DECODING THE BIOMOLECULAR LANDSCAPE OF PSYCHIATRIC DISORDERS FOR IMPROVING PATIENT STRATIFICATION	10
ANTI DIABETIC PERIPHERAL NEUROPATHY OF RED FRUIT (PANDANUS CONOIDES LAMK) OIL IN A RAT MODEL: INVOLVEMENT OF OXIDATIVE AND NEUROINFLAMMATORY PATHWAYS	10
415. SHARED GENETIC ARCHITECTURES BETWEEN METHAMPHETAMINE USE AND OTHER PSYCHIATRIC DISORDERS	10
401. EXPLORING FUNCTIONAL CONNECTIVITY IN ANXIETY: THE ROLE OF THE HIPPOCAMPUS, INSULA, AND AMYGDALA DURING A KETAMINE INFUSION	10
661. A SINGLE DOSE OF LYSERGIC ACID DIETHYLAMIDE (LSD) REDUCES ALCOHOL CONSUMPTION AND REVERTS DOPAMINERGIC (DA) DISFUNCTION IN MALE MICE	10
A SURVEY OF PATIENT– PHYSICIAN COMMUNICATION REGARDING TREATMENT PROSPECTS AND GOAL SETTING IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN JAPAN	9
ESTIMATING A PROBABILITY OF REDUCING RISKS ASSOCIATED WITH SMOKING CONVENTIONAL CIGARETTES USING THE THS2.2 (IQOS) TECHNOLOGY	9
EFFECTS ON THE THALAMUS AND INSULAR CORTEX DURING VOCAL EMOTION PROCESSING BY MODAFINIL AND BUPROPION: A PHARMACOLOGICAL MRI STUDY	9
PSYCHOPHARMACOLOGICAL CHALLENGES FOR HIV/AIDS PATIENTS WITH A HISTORY OF SUBSTANCE USE DISORDER EXPERIENCING PSYCHOTIC DEPRESSION	9
564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA	9
ET-1-INDUCED ATTENUATION OF MOR ACTIVITY DIFFERS BETWEEN MORPHINE AND FENTANYL	9
578. COLLECTING AND EVALUATING ANIMAL MODELS IN MENTAL HEALTH SCIENCE AND BUILDING AN ONLINE RESOURCE FOR RESEARCHERS: A WELLCOME INITIATIVE	9
PLASMA PHOSPHOETHANOLAMINE LEVELS AS A BIOMARKER FOR MONITORING MAJOR DEPRESSIVE DISORDER	9
211. C-REACTIVE PROTEIN AND RESPONSE TO ADD-ON DEXTROMETHORPHAN TREATMENT IN BIPOLAR DISORDERS: RESULTS FROM A PLACEBO-CONTROLLED TRIAL	9
TNFR2 LEVEL CHANGES IN PATIENTS WITH ALCOHOL DEPENDENCE DURING EARLY WITHDRAWAL	9
Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling	8
ACTIVATION OF PREFRONTAL PARVALBUMIN INTERNEURONS AMELIORATES WORKING MEMORY DEFICIT EVEN UNDER CLINICALLY COMPARABLE ANTIPSYCHOTIC TREATMENT IN A MOUSE MODEL OF SCHIZOPHRENIA	8
Inhibition of FKBP51 alleviates depressive-like behaviors via AKT/mTOR-dependent autophagy and synaptic plasticity	8
Erythrocyte Membrane Fatty Acid Composition as a Potential Biomarker for Depression	8
KNOCKDOWN OF CONNEXIN43 POTENTIATES ANTIDEPRESSANT EFFECT ON BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN PRIMARY CULTURED ASTROCYTES	8
Investigation of Neurofunctional Changes Over the Course of Electroconvulsive Therapy	8
EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OF THE LEFT DORSOLATERAL PREFRONTAL CORTEX ON SYMPTOM DOMAINS IN MOOD DISORDERS	8
IMPACT OF ANTIPSYCHOTICS ON PROLACTIN LEVELS IN PEDIATRIC AND ADOLESCENT PATIENTS WITH PSYCHIATRIC DISORDERS IN REAL-WORLD PSYCHIATRIC CLINICAL PRACTICE	8
IMPLICIT MEMORY AND EXPLICIT MEMORY PROFILES COMPARISONS BETWEEN PATIENTS WITH DIFFERENT MOOD DISORDERS	8
618. A RANDOMISED CONTROLLED TRIAL OF AN AI-ENABLED MENTAL HEALTH INTERVENTION FOR GENERALIZED ANXIETY DISORDER SYMPTOMS	8
DISRUPTION OF IMPULSIVITY BEHAVIORS IN CANNABIS USERS IN ADOLESCENTS AND YOUNG ADULTS: A META-ANALYSIS OF FUNCTIONAL NEUROIMAGING STUDIES	7
DOES COCAINE-INDUCED AGGRAVATION OF DEPRESSION ALTER MATE ATTRACTIVENESS IN MALES?	7
THE FUNCTIONAL CONNECTIVITY CHANGES OF THE RIGHT AMYGDALA ASSOCIATED WITH ANXIETY IN SCHIZOPHRENIA AND THE PRODROMAL PHASE	7
KNOWLEDGE AND OPINIONS ABOUT THE USE OF PSYCHEDELICS AMONG PSYCHIATRISTS IN KOREA: PRELIMINARY RESULTS	7
PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?	7
POGZ MUTANT MOUSE MODEL OF AUTISM SPECTRUM DISORDER SHOWS ABNORMAL NEURAL ACTIVITY IN THE ANTERIOR CINGULATE CORTEX DURING SOCIAL BEHAVIOR	7
GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION	7
MANIC BEHAVIOR MAY BE ATTENUATED BY MATRIX METALLOPROTEINASE-8 INHIBITOR VIA DECREASING NEUROINFLAMMATION IN A MOUSE MODEL OF BIPOLAR DISORDER	7
THE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRAUMA: A PATH ANALYSISTHE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRA	7
Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat	7
EFFECTS OF ANTIPSYCHOTIC USE BY PATIENTS WITH SCHIZOPHRENIA ON DECELERATION CAPACITY AND ITS RELATION TO THE CORRECTED QT INTERVAL	7
REGULATION OF THE TRANSITION BETWEEN MEMORY RECALL AND NON- RECALL BY HISTAMINE NEURON ACTIVITY	7
PROLINE-RICH TRANSMEMBRANE PROTEIN 2 KNOCK-IN MICE PRESENT NIGROSTRIATAL DOPAMINERGIC HYPERACTIVITY AND INCREASED SUSCEPTIBILITY TO L-DOPA-INDUCED MOTOR DEFICITS	7
THE SUCROSE INTAKE CHANGES STRESS-INDUCED BEHAVIOR VIA GLUCOSE METABOLISM AND NORADRENERGIC NEURONAL SYSTEM	6
PUTATIVE SEX DIFFERENCES IN THE EXCITABILITY OF BETA- ENDORPHIN AND NEUROPEPTIDE-Y-SECRETING NEURONS OF THE ARCUATE NUCLEUS	6
BLUNTED CORTISOL RESPONSE TO ACUTE PSYCHOSOCIAL STRESS IN WOMEN WITH PREMENSTRUAL DYSPHORIC DISORDER	6
THE IMPACT OF SLEEP JET LAG ON DEPRESSION DIFFERED BY SEX AND AGE ~ EVIDENCE FROM 27,916 TAIWAN BIOBANK PARTICIPANTS	6
PLASMA GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) IN ASTROCYTES CONTRIBUTES TO INCREASES IN THE PREVALENCE OF AUTISM SPECTRUM DISORDERS (ASD)	6
ANXIETY-LIKE BEHAVIOUR STUDY IN ADULT RAT STRESS MODEL INDUCED BY LIGHT DOMINANT EXPOSURE IN CIRCADIAN RHYTHM DISRUPTION	6
IRON DEPOSITIONS IN PREFRONTAL CORTEX INFLUENCES THE EFFECTIVENESS OF CORTICAL PAIRED ASSOCIATIVE STIMULATION IN HEROIN-DEPENDENT PATIENTS: A RANDOMIZED SHAM-CONTROLLED STUDY	6
VALUABLE INTERACTION WITH COGNITIVE REMEDIATION AND OPTIMAL ANTIPSYCHOTICS FOR RECOVERY IN SCHIZOPHRENIA (VICTORY-S): STUDY PROTOCOL FOR AN INTERVENTIONAL, OPEN-LABEL, RATER- BLINDED, RANDOMIZED COMPA	6
LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES	6
RTMS OVER THE DORSOLATERAL PREFRONTAL CORTEX INCREASES THE SERUM PROBDNF/BDNF RATIO: A SHAM-CONTROLLED STUDY IN SUBJECTS WITH COCAINE USE DISORDER	6
ADJUVANT CITHICOLINE AGAINST NEGATIVE SYMPTOMPS AND INTERLEUKIN 6 (IL-6) IN SCHIZOPHRENIA PATIENTS WITH RECEIVING RISPERIDONE TREATMENT	6
ROLES OF CANNABINOID TYPE 1 RECEPTORS IN THE MICE PREFRONTAL CORTEX FOR OBJECT LOCATION MEMORY	6
AN INSIGHT INTO GENETIC CONDITIONS ASSOCIATED WITH INTELLECTUAL DISABILITY IN INDONESIAN POPULATION	6
519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL	5
379. INCIDENCE OF PSYCHOSIS AND ITS RISK FACTORS AND MORTALITY IN NORTH KOREAN DEFECTORS COMPARED TO SOUTH KOREAN CONTROLS	5
551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES	5
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic	5
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine	5
Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice	5
506. MAPPING PERIPHERAL MOLECULAR MECHANISMS ASSOCIATED WITH LONG-LASTING EFFECTS OF EARLY LIFE STRESS: A TRANSCRIPTOMIC SET-BASED APPROACH	5
702. INNOVATIVE PERSPECTIVES IN NEUROPSYCHOPHARMACOLOGY: INSIGHTS FROM INDONESIA, NEWZEALAND AND AUSTRALIA	5
601. GENETIC POLYMORPHISMS ASSOCIATED WITH OPIOID SENSITIVITY IN PATIENTS UNDERGOING PALLIATIVE CARE AND GENERAL ANAESTHESIA	5
505. ROLE OF COGNITIVE FUNCTION IN FUNCTIONAL OUTCOME IN PSYCHOTIC AND AFFECTIVE INPATIENTS	5
AGE OF ONSET AFFECTS RELAPSE OF ALCOHOL USE DISORDER: A 7- YEAR RETROSPECTIVE COHORT STUDY	5
555. M4 MUSCARINIC RECEPTOR ACTIVATION IN THE CENTRAL AMYGDALA REDUCES STRESS-INDUCED ALCOHOL SEEKING IN ALCOHOL PREFERRING RATS	5
268. THE PRELIMINARY ANALYSIS OF YOGA THERAPY ON BURNOUT AMONG MEDICAL STAFF: A SINGLE-ARM PRE-POST INTERVENTION	5
635. THE NEUROBIOLOGICAL FOUNDATION FOR PHYSICAL EXERCISE RECOMMENDATIONS IN REDUCING SYMPTOMS OF ADHD	5
707. EXPERIENCES WITH NITAZENE WITHDRAWAL	5
209. OXYTOCINERGIC INPUT FOXYTOCINERGIC INPUT FROM THE PARAVENTRICULAR NUCLEUS TO THE NUCLEUS ACCUMBENS CORE MODULATES METHAMPHETAMINE-CONDITIONED PLACE PREFERENCE	5
671. PRENATAL STRESS EXPOSURE SHAPES CORTICOGENESIS THROUGH CELL FATE AND GENE REGULATORY NETWORKS WITH IMPLICATIONS FOR NEURODEVELOPMENTAL DISORDERS	5
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from cl	4
VITAMIN D AND DEPRESSION	4
ELEVATED MIDBRAIN INTERLEUKIN-6 AND IMPAIRED GOAL-DIRECTED BEHAVIOR IN OLD C57BL/6J MICE AFTER HINDLIMB UNLOADING	4
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE	4
Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects	4
THE NEURAL MECHANISM UNDERLYING THE ANTIDEPRESSANT EFFECTS ELICITED BY A SINGLE BOUT OF PHYSICAL EXERCISE	4
ASSOCIATION BETWEEN ADHD, METHYLPHENIDATE, AND PRECOCIOUS PUBERTY: A NATIONWIDE COHORT STUDY	4
AUTOMATED ANALYSIS OF RODENT BEHAVIOR USING INTELLIPROFILLER: A POTENTIAL TOOL FOR STUDYING NEURODEVELOPMENTAL DISORDER-LIKE MODEL MICE	4
Neurobiological influences on event perception: the role of catecholamines	4
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor	4
Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach	4
Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function	4

ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN	4
RAPID AND SUSTAINED IMPROVEMENT OF RESIDUAL ANHEDONIA SYMPTOMS IN PATIENTS WITH DEPRESSION USING ANALGESIC AGENT - DEZOCINE	4
PRACTICAL GUIDELINES ON THE USE OF CARIPRAZINE IN BIPOLAR 1 DISORDER: EXPERT CONSENSUS FROM SOUTHEAST ASIA	4
Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress–Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling	4
274. RETROSPECTIVE STUDY FOR CORRELATION WITH REDUCING ANTIPARKINSONIAN ANTICHOLINERGIC DRUGS AND ADVERSE EFFECTS	3
241. NEUROPHYSIOLOGICAL INSIGHTS INTO OMISSION MISMATCH NEGATIVITY: EVIDENCE FROM MACRO CALCIUM IMAGING IN RAT AUDITORY CORTEX	3
168. EXPLORING SAFE TAPERING OF ANTIPSYCHOTICS IN PATIENTS WITH REMITTED PSYCHOSIS: EMPLOYING ANIMAL MODEL AND COADMINISTRATION OF N-ACETYLCYSTEINE STUDY IN BENCH AND BESIDE	3
Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex	3
681. ENDOCANNABINOIDS AND INTRUSIVE MEMORIES: EVIDENCE FOR A ROLE OF ANANDAMIDE FROM TWO EXPERIMENTAL HUMAN STUDIES	3
Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use	3
445. DISTINCTIVE ASSOCIATION PATTERNS BETWEEN TOPOLOGICAL PROPERTIES OF BRAIN STRUCTURAL NETWORKS AND SOCIAL COGNITION IN EUTHYMIC BIPOLAR DISORDER	3
Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies	3
307. THE EFFECT OF SODIUM BENZOATE TREATMENT FOR TREATMENT RESISTANT SCHIZOPHRENIA AND ITS ASSOCIATION WITH GLUTAMATE CONCENTRATION: A PILOT STUDY WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY	3
367. DISCOVERING MARKERS OF INTRON RETENTION IN DEPRESSION AND ITS RESPONSE TO KETAMINE	3
628. DOPAMINERGIC CONTROL OF COMPULSIVE EATING	3
Illicit substance exposure in pregnancy and infant mortality risk: a nationwide Taiwan study	3
324. THEORETICAL DRUG SELECTION FOR BPSD	3
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential	3
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences	3
Thrombomodulin Improves Cognitive Deficits in Heat-Stressed Mice	3
347. PREDICTING RTMS TREATMENT RESPONSE IN DEPRESSION: USE OF MACHINE LEARNING MODELS TO IDENTIFY THE ROLES OF METABOLIC AND CLINICAL FACTORS	3
354. COGNITIVE FLEXIBILITY AS A POSSIBLE INDEX OF AGE-RELATED COGNITIVE DECLINE	3
201. DISCRIMINATION BETWEEN HEALTHY PARTICIPANTS AND PEOPLE WITH PANIC DISORDER BASED ON POLYGENIC SCORES FOR PSYCHIATRIC DISORDERS AND FOR INTERMEDIATE PHENOTYPES USING MACHINE LEARNING	3
Genetic overlap between treatment-resistant schizophrenia and smoking initiation	3
Sleep deprivation engages the orexin/hypocretin system to regulate food reward seeking	3
694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING	3
CAUSAL ASSOCIATIONS BETWEEN SCHIZOPHRENIA AND CANCERS: MENDELIAN RANDOMIZATION ANALYSES	3
488. SALIENCE NETWORK ALTERATIONS RELATED TO PERSONALITY TRAITS IN ADOLESCENTS WITH EXCESSIVE SMARTPHONE USE	3
437. EVALUATING APELIN AS A POTENTIAL BIOMARKER IN MAJOR DEPRESSIVE DISORDER: CORRELATION WITH CLINICAL SYMPTOMATOLOGY	3
643. RESTING-STATE FUNCTIONAL CONNECTIVITY ASSOCIATIONS WITH SUICIDAL IDEATION SEVERITY IN TREATMENT-RESISTANT DEPRESSION	3
PREDICTING RELAPSE FROM THE TIME TO REMISSION DURING THE ACUTE TREATMENT OF DEPRESSION: A RE-ANALYSIS OF THE STAR*D DATA	2
USING MULTI-SCALE ENTROPY ANALYSIS IN FMRI DATA TO EXAMINE THE COGNITIVE FUNCTION IN PATIENTS OF LATE-LIFE DEPRESSION AFTER ONE-YEAR FISH OIL SUPPLEMENT	2
ASSOCIATION OF NEUROFILAMENT LIGHT CHAIN WITH THE ANTIDEPRESSANT EFFECTS OF LOW-DOSE KETAMINE INFUSION AMONG PATIENTS WITH TREATMENT-RESISTANT DEPRESSION	2
612. EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A POOLED ANALYSIS OF PHASE 3 RANDOMIZED CONTROLLED TRIALS	2
475. DOES PRENATAL EXPOSURE TO LOW-DOSE DI-2-ETHYLHEXYL PHTHALATE IMPAIR NEURODEVELOPMENT IN A VAL66MET BDNF MOUSE MODEL?	2
425. EFFECT OF GAD67 DELETION IN THE THALAMIC RETICULAR NUCLEUS ON SENSORY GATING AND SLEEP SPINDLE ACTIVITY	2
SERUM EXTRACELLULAR VESICLE-DERIVED HSA-MIR-2277-3P AND HSA-MIR-6813-3P ARE POTENTIAL BIOMARKERS FOR MAJOR DEPRESSION	2
THE ASSOCIATION BETWEEN EARLY INITIATION OF ANTICONVULSANTS AND/OR ANTIDEPRESSANTS/ANTI-ANXIETY MEDICATIONS AND THE RISK OF POST-HERPETIC NEURALGIA IN PATIENTS 50 YEARS AND OLDER WITH NEWLY DIAGNOSED	2
THE ASSOCIATION OF KLOTHO/FIBROBLAST GROWTH FACTOR 23 WITH COGNITIVE FEATURES IN ELDERLY PATIENTS WITH BIPOLAR DISORDER	2
ENVIRONMENTAL ENRICHMENT IMPROVES THE DEFICITS OF HIPPOCAMPAL NEUROPLASTICITY AND COGNITION IN PRENATALLY ARIPIPRAZOLE EXPOSED MICE OFFSPRING	2
A MACHINE LEARNING APPROACH TO PREDICT THE THERAPEUTIC EFFICACY OF MOBILE NEUROFEEDBACK IN CHILDREN WITH ADHD	2
SOURCES OF INFORMATION ABOUT COVID-19 VACCINES FOR CHILDREN AND ITS ASSOCIATIONS WITH PARENTAL MOTIVATION TO HAVE THEIR CHILDREN VACCINATED IN TAIWAN	2
Corrigendum to: Naturally Derived Polyphenols Protect Against Corticosterone-Induced Changes in Primary Cortical Neurons	2
DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO PREDICT PLASMA AND BRAIN EXPOSURE FOLLOWING ADMINISTRATION OF VALPROIC ACID AND CLOBAZAM IN COMBINATION TREATMENT REGIMEN FOR DRA	2
EFFECTS OF BEHAVIORAL THERAPY ON MOUSE MODEL OF ASD ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX AND DNA METHYLATION ANALYSIS	2
410. SCREENING AND DIAGNOSIS OF DEPRESSION: CORRELATION OF GENOMIC ALTERATIONS WITH FUNCTIONAL MAGNETIC RESONANCE IMAGING	2
621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES	2
A TRANSDIAGNOSTIC PRODROME FOR SEVERE MENTAL DISORDERS: AN ELECTRONIC HEALTH RECORD STUDY	2
CAUSAL RELATIONSHIP BETWEEN SUBSTANCE USE AND INSOMNIA: A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY	2
CAUSAL RELATIONSHIPS BETWEEN STRUCTURAL BRAIN IMAGING MARKERS IN ADOLESCENCE AND PSYCHIATRIC DISORDERS IN ADULTHOOD	2
IS THERE A DIFFERENCE IN VESTIBULAR SYSTEM REACTIVITY BETWEEN PATIENTS WITH SCHIZOPHRENIA AND HEALTHY CONTROL PARTICIPANTS?	2
REPURPOSING CANDESARTAN, THE ANTIHYPERTENSIVE DRUG, FOR TREATMENT OF BIPOLAR DISORDER	2
SEX DIFFERENCES IN BRAIN EXCITABILITY REVEALED BY CONCURRENT ITBS/FNIRS	2
DECODING THE LINK AMONG SCHIZOPHRENIA, METABOLIC SYNDROME, AND THE SEROTONIN/MELATONIN PATHWAY USING THE MK-801 MOUSE MODEL	2
HETEROCYCLIC CATHINONES AS POTENTIAL SCHIZOPHRENIA THERAPEUTICS	2
THE INVOLVEMENT OF SPLENIC IMMUNE CELLS IN THE DEPRESSION-LIKE BEHAVIORS INDUCED BY CHRONIC SOCIAL DEFEAT STRESS	2
166. HAEMATOLOGICAL AND INFLAMMATORY MARKERS ASSOCIATED WITH NON-REMISSION AND TREATMENT RESISTANCE IN SCHIZOPHRENIA	2
542. THE PROTECTIVE ROLE OF PERINEURONAL NETS AGAINST STRESS	2
FACTORS ASSOCIATED WITH LONGITUDINAL DECREASE IN DOSES OF BENZODIAZEPINE HYPNOTICS IN PATIENTS WITH DEPRESSIVE DISORDERS	2
A STUDY OF DRY MOUTH AND GASTROINTESTINAL DISORDERS IN PATIENTS TAKING ANTIDEPRESSANT	2
OVEREXPRESSION OF VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2 IN NEURONS CAUSES ABNORMAL DENDRITIC MORPHOLOGY IN THE PREFRONTAL CORTEX AND COGNITIVE IMPAIRMENT	2
PREDICTING DEPRESSED AND ELEVATED MOOD SYMPTOMATOLOGY IN BIPOLAR DISORDER USING BRAIN FUNCTIONAL CONNECTOMES	2
MINOCYCLINE PREVENTS PREMATURE COGNITIVE DECLINE IN A MOUSE MODEL OF INTELLECTUAL DISABILITY INDUCED BY ZBTB18/RP58 HAPLOINSUFFICIENCY	2
THE EFFECT OF ATYPICAL GABAA/BENZODIAZEPINE RECEPTOR AGONIST ZOPICLONE ON EXPERIMENTAL SCHIZOPHRENIA MODELS	2
DEEP TRANSCRANIAL MAGNETIC STIMULATION TREATMENT FOR TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER: A CASE SERIES FROM THAILAND	2
WHITE MATTER ABNORMALITIES OF THE FRONTAL-STRIATAL-THALAMIC CIRCUITS IN INDIVIDUALS WITH ATTENUATED POSITIVE SYMPTOM SYNDROMES A PROBABILISTIC TRACTOGRAPHY STUDY	1
The role of pallidal substance P and neurokinin receptors in the consolidation of spatial memory of rats	1
SAFETY AND EFFICACY OF DIFFERENT INITIAL DOSES OF LURASIDONE IN THE SCHIZOPHRENIA TREATMENT: A RANDOMIZED, OPEN-LABEL, MULTI- CENTER STUDY	1
586. NEUROPSYCHIATRIC SYMPTOMS AS PREDICTORS FOR COGNITIVE IMPAIRMENT AND REVERT FACTORS FOR NORMAL COGNITION: A ONE-YEAR PROSPECTIVE COHORT STUDY	1
339. BARRIERS TO INTERNATIONAL RESEARCH IN NEUROPSYCHOPHARMACOLOGY FOR EARLY CAREER RESEARCHERS – PRELIMINARY DATA FROM THE 1ST CINP FELLOWSHIP PROGRAM SURVEY	1
655. EXPANDING ACCESS TO KETAMINE THROUGH REFORMULATION	1
471. MATERNAL IMMUNE ACTIVATION LEADS TO SCHIZOPHRENIA-RELATED BEHAVIOURAL AND NEUROPHYSIOLOGICAL DEFICITS IN MOTHERS AND JUVENILE OFFSPRING	1
PERIPHERAL BLOOD CELLS UNVEIL NEURAL AND SEX-RELATED SUBTYPES OF DEPRESSION: AN UNSUPERVISED MACHINE LEARNING APPROACH	1
556. LONGITUDINAL CORTICAL THICKNESS CHANGES IN FIRST EPISODE PSYCHOSIS: A TRIPLE-BLIND RANDOMISED PLACEBO-CONTROLLED MRI STUDY	1
SEX DIFFERENCES IN THE REDUCTION OF HOPELESSNESS IN Μ OPIOID RECEPTOR DEFICIENT MICE BY ADDITIVE EFFECTS OF Δ OPIOID RECEPTOR AGONISTS	1
USEFULNESS OF WHEEL-RUNNING BEHAVIOR AS A MOUSE MODEL OF BEHAVIORAL ADDICTION	1
ESCITALOPRAM VS BUPROPION AS ADJUNCTIVE TREATMENT FOR ACUTE BIPOLAR I DEPRESSION: A MULTI-CENTER OPEN LABEL TRIAL	1
Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia	1
206. EFFECTS OF SEMAGLUTIDE ON BODY WEIGHT IN CLOZAPINE-TREATED INDIVIDUALS WITH SCHIZOPHRENIA AND OBESITY: A RANDOMIZED CONTROLLED TRIAL	1
277. A LONG NONCODING ERNA FORMS R-LOOPS TO SHAPE EMOTIONAL EXPERIENCE-INDUCED BEHAVIORAL ADAPTATION	1
527. DYNAMIC REWIRING OF NEURAL CIRCUITS IN THE PRELIMBIC CORTEX IN METH ABSTINENCE	1
423. RAMELTEON REDUCED ANXIETY/DEPRESSION AND SLEEP PROBLEMS AMONG SHIFT WORKERS	1
648. A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF LURASIDONE IN IMPROVING COGNITIVE IMPAIRMENT IN EUTHYMIC PATIENTS WITH BIPOLAR DISORDER	1
RELATIONSHIPS BETWEEN SCHIZOPHRENIA SEVERITY AND INFLAMMATORY BIOMARKER: NEUTROPHIL/LYMPHOCYTE RATIO, MONOCYTE/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO	1
CLINICAL BENEFIT AND UTILITY OF ARIPIPRAZOLE ONCE MONTHLY IN ROUTINE PRACTICE FOR KOREAN BIPOLAR PATIENTS	1
ADMINISTRATION OF ANTICANCER DRUG S-1 INCREASES NERVE DENSITY IN THE CORNEA AND INDUCES NEUROINFLAMMATION IN TRIGEMINAL GANGLIA IN RATS	1
Correction to: Identification of Phosphodiesterase-7A (PDE7A) as a Novel Target for Reducing Ethanol Consumption in Mice	1
Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders	1
424. IDENTIFYING SPECIFIC EEG MARKERS OF INTERNET GAMING DISORDER AND THE CORRESPONDING TDCS INTERVENTION: A RANDOMIZED CONTROLLED DOUBLE-BLIND STUDY	1
175. EPIGENETIC INSIGHTS INTO SOCIAL COGNITION: SEX-SPECIFIC INFLUENCES OF BDNF AND OXYTOCIN RECEPTOR GENE METHYLATION	1
296. A POPULATION-BASED STUDY ON LONG-TERM MORTALITY RISK ASSOCIATED WITH CLOZAPINE USE AMONG PATIENTS WITH SCHIZOPHRENIA	1
539. EARLY ASSERTIVE PHARMACOTHERAPY INTERVENTION STUDY FOR STIMULANT ASSOCIATED PSYCHOSIS—A 24-MONTH PROSPECTIVE RANDOMIZED CONTROLLED TRIAL	1
17β-Estradiol Ameliorates Postoperative Cognitive Dysfunction in Aged Mice via miR-138-5p/SIRT1/HMGB1 Pathway	1
OMEGA-3 FATTY ACIDS FOR INFLAMED DEPRESSION – A MATCH/MISMATCH STUDY	1
568. THE LONG-TERM EFFECTS OF REPRODUCTIVE EXPERIENCE ON ANXIETY AND ITS PHARMACOLOGICAL TREATMENT: A CROSS-SPECIES APPROACH IN RATS AND HUMANS	1